Self-reported allergy to medications containing the same excipients as SARS-CoV2 vaccines: importance of skin testing with excipients

Ital J Dermatol Venerol. 2023 Feb;158(1):72-73. doi: 10.23736/S2784-8671.22.07410-2. Epub 2022 Nov 24.

Authors

Filippo Biondi¹, Leonardo Bianchi², Marta Tramontana¹, Rossella Marietti¹, Alessandro D'Arpino³, Katharina Hansel¹, Luca Stingeni¹

Affiliations

¹ Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
² Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy - leonardo.bianchi@unipg.it.
³ Hospital Pharmacy Unit, Santa Maria della Misericordia Hospital, Hospital of Perugia, Perugia, Italy.

PMID: 36421077
DOI: 10.23736/S2784-8671.22.07410-2

No abstract available

MeSH terms

COVID-19* / prevention & control
Excipients / adverse effects
Humans
Hypersensitivity*
RNA, Viral
SARS-CoV-2
Self Report
Vaccines*

Substances

Excipients
RNA, Viral
Vaccines